Extended Access of Momelotinib in Adults With Myelofibrosis

Clinical trial NCT03441113 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03441113
Sponsor: GlaxoSmithKline
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms Post-polycythemia Vera Myelofibrosis (Post-PV MF)Primary Myelofibrosis (PMF)Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)Primary Myelofibrosis

Start date: 2018-05-03
Primary completion: 2026-12-11
Enrollment: 237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.